N

NewGLab Pharma Co Ltd
KOSDAQ:214870

Watchlist Manager
NewGLab Pharma Co Ltd
KOSDAQ:214870
Watchlist
Price: 6 915 KRW -27.44% Market Closed
Market Cap: 323.6B KRW
Have any thoughts about
NewGLab Pharma Co Ltd?
Write Note

Net Margin
NewGLab Pharma Co Ltd

4.8%
Current
-155%
Average
3.3%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
4.8%
=
Net Income
290.5m
/
Revenue
6.1B

Net Margin Across Competitors

Country KR
Market Cap 323.6B KRW
Net Margin
5%
Country JP
Market Cap 15.6T JPY
Net Margin
37%
Country CN
Market Cap 288.1B CNY
Net Margin
14%
Country US
Market Cap 28.2B USD
Net Margin
12%
Country SE
Market Cap 283.3B SEK
Net Margin
19%
Country US
Market Cap 21.9B USD
Net Margin
17%
Country US
Market Cap 20.3B USD
Net Margin
8%
Country US
Market Cap 17.5B USD
Net Margin
41%
Country IL
Market Cap 14.2B USD
Net Margin
-164%
Country UK
Market Cap 10.3B GBP
Net Margin
13%
Country JP
Market Cap 1.3T JPY
Net Margin
10%
No Stocks Found

NewGLab Pharma Co Ltd
Glance View

Market Cap
323.6B KRW
Industry
Electrical Equipment

NewGLAB Pharma Co., Ltd. engages in the manufacture of closed-circuit television camera and equipment. The company is headquartered in Bucheon, Gyeonggi-Do. The company went IPO on 2015-10-13. The firm's product portfolio consists of general analog cameras that used for CCTVs, high definition (HD) analog cameras, HD-serial digital interface (SDI) cameras, extend (EX)-SDI cameras, internet protocol (IP) cameras that used for network CCTVs, digital video recorders (DVRs) that used for image storage devices, network video recorders (NVRs) and others. In addition, the Company is involved in the business of 5G smartphone distribution. The firm distributes its products within domestic market and to overseas markets.

Intrinsic Value
84.39 KRW
Overvaluation 99%
Intrinsic Value
Price
N

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
4.8%
=
Net Income
290.5m
/
Revenue
6.1B
What is the Net Margin of NewGLab Pharma Co Ltd?

Based on NewGLab Pharma Co Ltd's most recent financial statements, the company has Net Margin of 4.8%.